Skip navigation

Change Symbol: Lookup

CATAMARAN CORPORATION

CATAMARAN CORPORATION is a provider of pharmacy benefits management (PBM) services and healthcare IT solutions to the healthcare benefits management industry.


Symbol: N/A
Exchange(s): N/A
Industry: Business Services (Computer Software & Processing)
5-Star Rating:
ANNUAL FINANCIALS
  Dec 31, 2014
12 Months
us$
Dec 31, 2013
12 Months
us$
Dec 31, 2012
12 Months
us$
3Yr.
Growth
% Change
Total Revenue ($000) 21,581,890 14,780,094 9,940,120 69.12
Earnings before Interest & Tax ($000) 568,996 443,768 217,019 65.07
Profit/Loss ($000) 317,293 262,170 116,658 56.80
Earnings per Share 1.53 1.27 0.70 27.39
Total Assets ($000) 9,324,185 7,995,763 7,385,127 115.43
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity 6.23 5.51 4.42  
Employees N/A 4,000 3,300  
 
Trailing 12 Month Results
  12 Months ended
Mar 31, 2015, us$
12 Months ended
Mar 31, 2014, us$
%Change
Total Revenue ($000) 22,646,671 16,474,857 48.81
Profit/Loss ($000) 340,541 274,207 35.25
Earnings per Share 1.65 1.33 34.43
Dividends Per Share 0.00 0.00
Number of Shares 208,012,259 206,854,499  
 
COMPANY INFORMATION
Report on Business Magazine Top 1000 Ranking
Profit: 0066 Revenue: 0016 Assets:  0070  
 
Key Personnel
CEO: Mark Thierer, President & C.E.O. & Chairman
CFO: Mike Shapiro, S.V.P. & C.F.O.
HR: Mike Rude, S.V.P. & Chief HR Officer
 
Contact Information
Address: 1600 McConnor Parkway,
Schaumburg,
IL
Phone: 800-282-3232
Fax: 224-231-1901
Web Address: www.catamaranRx.com
E-Mail : investors@sxc.com
Investor Relations: Dave Mason, 416-815-0700
 
Company Type: Private Company Status: Active
Auditors: Kpmg
Transfer Agent: Not Applicable
Incorporation: Cbca, Mar 19, 1993
 
 
 


All information on this site is compiled by The Globe and Mail Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, The Globe and Mail Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.

Copyright © 2015 The Globe and Mail Inc. All rights reserved.